U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Thursday.
Shares of Jabil Inc. JBL rose sharply during Wednesday's session after the company reported better-than-expected second-quarter financial results and raised its FY25 guidance.
Jabil reported second-quarter adjusted earnings per share of $1.94, beating the analyst consensus estimate of $1.83. Quarterly sales of $6.73 billion outpaced the analyst consensus estimate of $6.408 billion.
Jabil shares jumped 5.1% to $146.67 on Thursday.
Here are some other big stocks recording gains in today's session.
- ProAssurance Corporation PRA shares jumped 47.8% to $22.98 after the company announced it will be acquired by The Doctors Company for $25.00 per share in cash.
- ARS Pharmaceuticals, Inc. SPRY gained 24.77% to $14.53 following fourth-quarter results.
- China Liberal Education Holdings Limited CLEU shares rose 19.8% to $2.42.
- Regencell Bioscience Holdings Limited RGC jumped 19.5% to $36.77.
- Capricor Therapeutics, Inc. CAPR rose 13.7% to $13.90 following strong quarterly results.
- Titan Machinery Inc. TITN gained 12.9% to $16.63 following strong quarterly sales.
- Carvana Co. CVNA gained 9.9% to $193.50 after Piper Sandler upgraded the stock from Neutral to Overweight..
- Gambling.com Group Limited GAMB shares rose 9.4% to $13.65 after reporting upbeat quarterly results.
- Immunocore Holdings plc IMCR gained 9% to $31.31.
- Darden Restaurants, Inc. DRI rose 7.7% to $202.57 after the company issued FY25 sales guidance above estimates.
- QXO, Inc. QXO gained 7.4% to $14.02. On Thursday, QXO disclosed entering into a definitive merger agreement to acquire Beacon for $124.35 per share in cash.
- Five Below, Inc. FIVE rose 6.8% to $80.73 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.
- The Boston Beer Company, Inc. SAM gained 4.4% to $228.68. Citigroup analyst Filippo Falorni upgraded Boston Beer from Neutral to Buy and raised the price target from $265 to $280.
Now Read This:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.